Arzeda Secures $12,000,000 Series A Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=86e9445a-7723-4bdd-8b95-c724e0c0cb96&Preview=1 -
Date
2/27/2009 -
Company Name
Arzeda -
Mailing Address
Undisclosed Seattle, WA 98100 -
Company Description
ARZEDA has the world-leading computational enzyme design technology and is changing the way people think about biocatalysis. ARZEDA was founded by David Baker and three senior members of his lab to commercialize and further develop its computational enzyme design technology. ARZEDA’s team includes the inventors of the platform and brings more than 20 years of combined experience in the field of computational and experimental protein engineering. -
Website
Undisclosed
-
Transaction Type
Venture Equity -
Transaction Amount
$12,000,000 -
Transaction Round
Series A -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
OVP Venture Partners -
Venture Investor
WRF Capital
